1-6 of 6
Melanie Braig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCR-ABL Cooperates With a “Telomere-Associated Secretory Phenotype” (TASP) To Facilitate Malignant Proliferation Of Hematopoietic Stem Cells

Tim H. Brümmendorf, MD, Nora Pällmann, Michael Preukschas, Doris Steinemann, PD Dr. rer. nat., Winfried Hofmann, Dr. rer. nat., Anne Gompf, Karl L. Rudolph, Carsten Bokemeyer, MD, Steffen Koschmieder, Andreas Schuppert, Stefan Balabanov, Melanie Braig
Journal: Blood
Blood (2013) 122 (21): 3976.
https://doi.org/10.1182/blood.V122.21.3976.3976
Published: 2013
Journal Articles

BCL6 Is Required for the Maintenance of Leukemia-Initiating Cells In Chronic Myeloid Leukemia

Christian Hurtz, Cihangir Duy, Leandro Cerchietti, MD, Katerina Chatzi, Eugene Park, Lars Klemm, Yong-mi Kim, Michael Kahn, Melanie Braig, PhD, Martin C. Muller, Andreas Hochhaus, B. Hilda Ye, PhD, Ari M. Melnick, Markus Muschen
Journal: Blood
Blood (2010) 116 (21): 202.
https://doi.org/10.1182/blood.V116.21.202.202
Published: 2010
Journal Articles

Resistance to Danusertib (formerly PHA-739358) in BCR-ABL-Positive Cells Is Mediated by Upregulation of the Drug Transporter Abcg2 and Can Be Suppressed in Vitro by Combination Treatment with Imatinib.

Tim H Brummendorf, MD, Artur Gontarewicz, Gunhild Keller, Jürgen Moll, Melanie Braig, Imke Rohe, Edgar Jost, Oliver Galm, Carsten Bokemeyer, MD, Tessa Holyoake, Stefan Balabanov
Journal: Blood
Blood (2009) 114 (22): 1724.
https://doi.org/10.1182/blood.V114.22.1724.1724
Published: 2009
Journal Articles

Functional p53 Is Required for Effective Telomerase Inhibition in BCRABL- Positive CML Cells in Vitro

Ute Brassat, Stefan Balabanov, Melanie Braig, Daniel Bali, Kerstin Borgmann, Tim H. Brummendorf
Journal: Blood
Blood (2008) 112 (11): 572.
https://doi.org/10.1182/blood.V112.11.572.572
Published: 2008
Journal Articles

Identification of Novel Biomarkers for Prediction of Response to Tyrosine Kinase Inhibitors (TKIs) by Proteomic Profiling of Imatinib as Well as 2 nd and 3 rd Generation TKIs in Vitro

Stefan Balabanov, MD/PhD, Thoma Wilhelm, PhD, Simone Venz, PhD, Christine Barret, Gunhild Keller, MD, Mirja Bernhardt, Artur Gontarewicz, MD, Melanie Braig, PhD, Reinhard Walther, PhD, Tim H. Brummendorf, MD
Journal: Blood
Blood (2008) 112 (11): 336.
https://doi.org/10.1182/blood.V112.11.336.336
Published: 2008
Journal Articles

Impaired Histone H3 Lysine 9 Methylation Accelerates Ras-Driven Lymphomagenesis by Disabling Cellular Senescence.

Melanie Braig, M.Sc., Christoph Loddenkemper, M.D., Antoine H.F.M. Peters, Ph.D., Harald Stein, M.D., Bernd Dorken, M.D., Thomas Jenuwein, Ph.D., Clemens A. Schmitt, M.D.
Journal: Blood
Blood (2004) 104 (11): 346.
https://doi.org/10.1182/blood.V104.11.346.346
Published: 2004